Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

Polycystic ovarian shape is a genetic sign of PCOS and its hormonal and metabolic features can be inherited.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Early life factors, including a mother's health and environment, can affect the chances of developing polycystic ovary syndrome later in life.

Spexin levels are lower in PCOS patients and linked to metabolic and hormonal issues.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

PCOS has three subtypes, with 11-oxygenated androgens increasing metabolic risk.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Machine learning identified three unique subtypes of androgen excess in women with PCOS, each with different metabolic risks.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Birth control pills with cyproterone acetate and drosperinone can reduce excessive hair growth in women with PCOS, but they may not be right for everyone.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Anovulatory PCOS patients are younger with longer cycles and higher blood pressure and hormone levels.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Women with PCOS have more emotional and body image issues than healthy women.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Polycystic Ovary Syndrome (PCOS) symptoms vary globally, with bloating, high cholesterol, and glucose levels being common; the current diagnostic criteria may need refining.

Women with PCOS often experience mental health issues like depression and anxiety.

A new low-cost method can accurately detect PCOS early by measuring free testosterone levels.

Unmarried women with PCOS in Pakistan face stigma and use various strategies to cope, needing better support and accurate information.